Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo
暂无分享,去创建一个
S. Horrigan | T. Sepehrizadeh | M. de Veer | I. Savvidou | A. Spencer | S. Mithraprabhu | T. Khong | I. Carmichael | S. Whish